Trades on 3 secondary markets

Generate Biomedicines

Generate Biomedicines is a Somerville, Massachusetts therapeutics company pioneering Generative Biology, a machine-learning-driven approach to de novo protein design across antibodies, peptides, enzymes, and gene therapies. Founded out of Flagship Pioneering and chaired by Noubar Afeyan, the company

minimal 10.9 / 100 0 APIs View provider profile →

Generative Biology Protein Design De Novo Design Diffusion Models Antibodies Drug Discovery

Generate Biomedicines is an API provider whose private shares are listed on 3 secondary markets: Forge Global, Hiive, EquityZen.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.